10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $421,699 | -71.5% | 10,223 | -61.4% | 0.00% | -100.0% |
Q2 2023 | $1,478,866 | -4.4% | 26,484 | -4.5% | 0.00% | 0.0% |
Q1 2023 | $1,546,778 | +337.2% | 27,725 | +185.6% | 0.00% | – |
Q4 2022 | $353,760 | +27.7% | 9,708 | -0.1% | 0.00% | – |
Q3 2022 | $277,000 | -92.1% | 9,713 | -58.8% | 0.00% | -100.0% |
Q4 2021 | $3,509,000 | -46.5% | 23,560 | -47.7% | 0.00% | -50.0% |
Q3 2021 | $6,554,000 | -37.6% | 45,015 | -16.0% | 0.01% | -40.0% |
Q2 2021 | $10,496,000 | -67.5% | 53,599 | -69.9% | 0.01% | -69.7% |
Q1 2021 | $32,263,000 | +26.1% | 178,251 | -1.3% | 0.03% | +17.9% |
Q4 2020 | $25,578,000 | +0.5% | 180,632 | -11.5% | 0.03% | -15.2% |
Q3 2020 | $25,461,000 | +23.3% | 204,216 | -11.7% | 0.03% | +17.9% |
Q2 2020 | $20,654,000 | -53.7% | 231,269 | -67.7% | 0.03% | -26.3% |
Q1 2020 | $44,650,000 | +28.7% | 716,478 | +57.5% | 0.04% | -9.5% |
Q4 2019 | $34,686,000 | +22.5% | 454,894 | -19.0% | 0.04% | +16.7% |
Q3 2019 | $28,308,000 | – | 561,674 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |